PXD-101 |
PX-105684 |
NSC726630 |
BELINOSTAT |
BELEODAQ |
rxcui:1543543 |
chembl:CHEMBL408513 |
pubchem.compound:6918638 |
chemidplus:866323-14-0 |
drugbank:05015 |
FDA Approval | Peripheral T-cell lymphoma |
Drug Class | Small molecule inhibitor |
FDA Approval | not approved |
Drug Class | Small molecule |
Drug Indications | antineoplastic agent |
inhibitor (inhibitory) |
Notes | |
Mechanism of Interaction | Histone deacetylase inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Notes | |
Trial Name | PXD101 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | PXD101 |
Notes |
inhibitor (inhibitory) |
Trial Name | PXD101 |
Novel drug target | Established target |
Direct Interaction | yes |
inhibitor (inhibitory) |
Trial Name | PXD101 |
Novel drug target | Established target |
Notes |
inhibitor (inhibitory) |
Trial Name | PXD101 |
Novel drug target | Established target |
Mechanism of Interaction | Histone deacetylase inhibitor |
inhibitor (inhibitory) |
Notes | |
Trial Name | PXD101 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Histone deacetylase inhibitor |
Trial Name | PXD101 |
inhibitor (inhibitory) |
Mechanism of Interaction | Histone deacetylase inhibitor |
Direct Interaction | yes |
Trial Name | PXD101 |
inhibitor (inhibitory) |
Notes | |
Mechanism of Interaction | Histone deacetylase inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Notes | |
Direct Interaction | yes |
Mechanism of Interaction | Histone deacetylase inhibitor |
BELEODAQ | Trade Name |
Drug Class | Small molecule inhibitor |
FDA Approval | Peripheral T-cell lymphoma |
Drug Indications | antineoplastic agent |
Drug Class | Small molecule |
FDA Approval | not approved |
CHEMBL408513 | ChEMBL Drug ID |
BELINOSTAT | Primary Drug Name |
BELINOSTAT | Drug Generic Name |
PXD 101 | Drug Synonym |